Differentials

Nonimmune fetal hydrops

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Hydrops fetalis consists of generalized subcutaneous edema and fluid collections in some or all serous cavities.

Placental calcification, oligohydramnios, and intrauterine growth restrictions may be associated with congenital infections.[38][39]

INVESTIGATIONS

Maternal serum antibodies are negative in nonimmune fetal hydrops. There are more than 80 causes of fetal hydrops.

Nonimmune hydrops carries a high rate of infant mortality, and in many patients (17%) its cause remains indeterminate after diagnostic workup.[37]

Parvovirus infection

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

History of environmental exposure to parvovirus may arouse suspicion of possible infection in asymptomatic people.

Symptoms include maternal fever, myalgia, coryza, headache, nausea, and erythematous, maculopapular exanthema on the trunk and limbs. Arthropathy and arthritis are also common in women and adolescents.

Progressive fetal anemia, due to preferential destruction of immature red blood cells (RBCs) by the virus, leads to hydrops and intrauterine fetal death.[29][40]

INVESTIGATIONS

Viral-specific IgM appears about 10 to 12 days after infection. Fetal infection is confirmed by analyzing amniotic fluid, cord blood, or serous fluid for viral DNA or RNA by polymerase chain reaction.[40]

Non-RhD hemolytic disease

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Usually transfusion-induced. The mechanism for fetal anemia is hemolysis and erythroid suppression.

Prior obstetric history does not reliably predict occurrence in subsequent pregnancy, and maternal antibody titer does not correlate with severity.[2]

Kell alloimmunization is the most common non-RhD hemolytic disease, with an incidence of 0.1% to 0.2% in the obstetric population.[2]

INVESTIGATIONS

Serum antibodies can be detected in the maternal blood. Although the titer is not as reliable as in RhD disease, severe disease is unusual with titers <1:32, with the exception of anti-Kell antibodies where significant fetal disease can occur at much lower titers.

Middle cerebral artery (MCA) Doppler should be performed and has been shown to be reliable for fetal anemia detection.

Fetal hemoglobin should be assessed by cordocentesis when noninvasive testing (MCA Doppler) is abnormal.[2]

Placental chorioangioma

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

May be present in up to 1% of pregnancies.[29]

Large placental masses of ≥5 cm may produce complications such as fetal anemia, hydrops, and polyhydramnios, and poor perinatal outcome.[29]

INVESTIGATIONS

A solid placental mass is detected by standard 2-dimensional sonography, and color Doppler sonography reveals a pulsatile mass.

Maternal serum alpha-fetoprotein may be high in association with a placental chorioangioma. Doppler velocimetry of the MCA may be consistent with fetal anemia.[41]

Fetomaternal hemorrhage

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Severe, acute fetomaternal hemorrhage may be entirely asymptomatic or manifest as a reduction in perceived fetal movements by the mother. Clinical symptoms are usually nonspecific.

INVESTIGATIONS

Peak systolic velocity on MCA Doppler may be increased.

Kleihauer-Betke test (persistence of fetal RBCs in maternal serum after denaturation by strong acid) or flow cytometry is also helpful.[29]

Twin-twin transfusion syndrome (TTTS)

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Develops in association with monochorionic twin placentation, usually between 15 and 26 weeks' gestation. It is found in 5.5% to 17.5% of all monochorionic pregnancies.[42]

INVESTIGATIONS

Ultrasound findings include polyhydramnios in one twin (recipient), and amniotic sac and oligohydramnios in the other (donor).

Growth of fetuses is usually discordant.[42]

Hydrops may develop in later stages of the disease, usually in the recipient co-twin.

Perinatal mortality may reach 80% to 100% when untreated.[42]

Twin anemia-polycythemia sequence (TAPS)

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Develops in monochorionic twins and is characterized by a large intertwin hemoglobin difference without the abnormal amniotic fluid seen in TTTS.

Results mainly due to slow intertwin blood transfusion leading to anemia for the donor and polycythemia for the recipient.

Can occur spontaneously (3% to 5%) or after laser surgery for TTTS (2% to 13%).[43]

INVESTIGATIONS

Absence of ultrasound finding of twin oligohydramnios (donor) and polyhydramnios (recipient) sequence.

Peak systolic velocity on MCA Doppler: donor >1.5 MoM (anemia); recipient <1.0 MoM (polycythemia).

Use of this content is subject to our disclaimer